Cardica To Announce Fiscal 2013 Second Quarter Financial Results On Thursday, January 31, 2013

Cardica To Announce Fiscal 2013 Second Quarter Financial Results On Thursday,
                               January 31, 2013

PR Newswire

REDWOOD CITY, Calif., Jan. 28, 2013

REDWOOD CITY, Calif., Jan. 28, 2013 /PRNewswire/ -- Cardica, Inc. (Nasdaq:
CRDC) today announced that it will release financial results for its fiscal
second quarter ended December 31, 2012, on Thursday, January 31, 2013, after
the markets close. Cardica's management will host a conference call at 4:30
p.m. Eastern Time to discuss the financial results and provide an update on
the company's business.

Conference Call Details
To access the live conference call on January 31, 2013 at 4:30 p.m. Eastern
Time via phone, please dial 866-804-6923 from the United States and Canada or
857-350-1669 internationally. The conference ID is 26563845. Please dial in
approximately 10 minutes prior to the start of the call. A telephone replay
will be available beginning approximately two hours after the call through
February 7, 2013, and may be accessed by dialing 888-286-8010 from the United
States and Canada or 617-801-6888 internationally. The replay passcode is

To access the live and subsequently archived webcast of the conference call,
go to the Investor Relations section of the company's website at Please connect to the website at least 15 minutes prior to
the presentation to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents
Network. Individual investors can listen to the call at,
Thomson's individual investor portal, powered by StreetEvents. Institutional
investors can access the call via Thomson StreetEvents at, a password-protected event management site.

Cardicadesigns and manufactures proprietary stapling and anastomotic devices
for cardiac and laparoscopic surgical procedures.Cardica's technology
portfolio is intended to minimize operating time and enable minimally-invasive
and robot-assisted surgeries. Cardica manufactures and markets its automated
anastomosis systems, the C-Port^® Distal Anastomosis Systems and PAS-Port^®
Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery,
and has shipped over 42,900 units throughout the world. In
addition,Cardicais developing the Cardica MicroCutter XCHANGE™ 30, a
cartridge-based microcutter device with a five-millimeter shaft diameter, and
the Cardica MicroCutter XPRESS™ 30, a true multi-fire laparoscopic stapling
device. Both MicroCutter devices are designed to be used in a variety of
procedures, including bariatric, colorectal, thoracic and general surgery. The
Cardica MicroCutter XCHANGE 30 and XPRESS 30 products require 510(k) review
and are not yet commercially available in the U.S.

SOURCE Cardica, Inc.

Contact: Bob Newell, Vice President, Finance and Chief Financial Officer,
Press spacebar to pause and continue. Press esc to stop.